Bixiye
QP4-21 Commercial Pharmacy Benefit Exclusion for OxlumoTM
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Natiijooyinka Raadinta
Soo bandhiga 2251 - 2260 ee natiijooyinka 3701
Bixiye
P93R1-20 Update: Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2021
Bixiye
P9-21 New Claim Edits for Professional Lab Claims Missing Required Data
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2021
Bixiye
P10-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective April 5, 2021
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2021
Bixiye
P7-21 Change in Liability for Members of Other Blue Plans
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2021
Bixiye
QP5-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Sucraid® (sacrosidase) PAQL
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP1-21 Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
QP3-21 Commercial and MHCP Pharmacy Benefit Exclusion for Barhemsys® and Monoferric®
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021